Difference between revisions of "Part:BBa K5439003"

(→‎Characterization)
(→‎Usage and Biology)
Line 14: Line 14:
  
 
Rifampicin (RAMP) is an antibiotic widely used in the treatment of severe bacterial infections such as tuberculosis, meningitis, leprosy, and HIV-associated infections. RAMP residues contaminate water sources, primarily through human excretions (urine and feces) and waste generated by the pharmaceutical industry and animal husbandry. Due to its high solubility and environmental stability, RAMP is not fully removed by wastewater treatment plants, contributing to the development of antibiotic-resistant bacteria (ARB) 3 .
 
Rifampicin (RAMP) is an antibiotic widely used in the treatment of severe bacterial infections such as tuberculosis, meningitis, leprosy, and HIV-associated infections. RAMP residues contaminate water sources, primarily through human excretions (urine and feces) and waste generated by the pharmaceutical industry and animal husbandry. Due to its high solubility and environmental stability, RAMP is not fully removed by wastewater treatment plants, contributing to the development of antibiotic-resistant bacteria (ARB) 3 .
−
 
−
<html>
 
−
<head>
 
−
<style>
 
−
    figure {
 
−
        text-align: center;
 
−
    }
 
−
 
−
    figcaption {
 
−
        font-size: 12px;
 
−
    }
 
−
 
−
</style>
 
−
</head>
 
−
<body>
 
−
    <figure>
 
−
        <img src="https://static.igem.wiki/teams/5439/constructo-de-rifmo.png" width="600">
 
−
        <figcaption><b>Figure 1.</b> Transformation of pET28b(+)_TjPCs plasmid into <i>E. coli</i> BL21 cells.</figcaption>
 
−
    </figure>
 
−
</body>
 
−
</html>
 
  
 
=Selecting Fluorescent Proteins=
 
=Selecting Fluorescent Proteins=

Revision as of 03:14, 2 October 2024


FRET-based system for the detection of rifampicin

FRET-based sensor system for the detection of rifampicin that consists of rifampicin monooxygenase (K4447003), an enzyme that catalyzes the hydroxylation of rifampicin, flanked by two fluorescent proteins: ECFP (BBa_K1159302) as energy donor and mVenus (BBa_K1907000) as an energy acceptor.

Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    INCOMPATIBLE WITH RFC[21]
    Illegal XhoI site found at 1913
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    COMPATIBLE WITH RFC[25]
  • 1000
    INCOMPATIBLE WITH RFC[1000]
    Illegal BsaI.rc site found at 2562

Usage and Biology

Rifampicin (RAMP) is an antibiotic widely used in the treatment of severe bacterial infections such as tuberculosis, meningitis, leprosy, and HIV-associated infections. RAMP residues contaminate water sources, primarily through human excretions (urine and feces) and waste generated by the pharmaceutical industry and animal husbandry. Due to its high solubility and environmental stability, RAMP is not fully removed by wastewater treatment plants, contributing to the development of antibiotic-resistant bacteria (ARB) 3 .

Selecting Fluorescent Proteins

FRET (Fluorescence Resonance Energy Transfer) is often used in the design of biosensors as it allows for the specific and sensitive detection of biomolecules in a highly specific manner with high sensitivity, without the need to induce a change in the biomolecule. The fluorescence of the acceptor molecule is activated only when both the donor fluorophore and the acceptor molecule are in proximity. This means that any changes in their surrounding environment that affect the distance between them will also impact the fluorescence of the molecule. This mechanism of action enables the detection of changes in the environment, even if they are subtle, without the need to genetically modify the molecule. FRET is a non-radiative process, which means it does not produce any ionizing radiation. This makes this type of biosensor safer to use and handle compared to others. Additionally, they are very sensitive and versatile biosensors, allowing them to detect the presence of a wide variety of biomolecules, as well as changes in the environment. They can detect protein-protein interactions, monitor changes in pH, measure enzyme activity, among others 2 .

Characterization

With the DNA fragments purified from an agarose gel, we performed ligation at a molar ratio of 1:5 for vector and insert, as shown in Figure 3. The total vector concentration was 100 nanograms, whereas the reaction volume was 20 µL. Next, Table 2 displays the protocol followed for the reaction.

Table 1. Components and volumes for the PCR with DreamTaq polymerase protocol.
Reactive Quantity
10X DreamTaq buffer 5 µL
dNTP Mix (10 mM each) 1 µL
IUpstream primer 1 µL
Downstream primer 1 µL
DNA temple 10 pg - 1 µL
DreamTaq Polymerase 0.25 µL
Nuclease-free water To 50 µL
Total volume 50 µL


Once we obtained


Figure 3. Escherichia coli TOP10 colonies transformed with BBa_K4447004 cloned in pBAD/Myc-HisB. Bacteria were grown in LB medium with carbenicillin.


Table 1. Restriction digest conditions
Componets 2-3 fragment assembly Positive control
Total amount of fragments 0.02 - 0.5 pool 10 µL
Gibson Assembly 2X Master Mix 10 µL 10 µL
Nuclease-Free Water To 20 µL 0 µL
Total volume 20 µL 20 µL


Figure 3. Bacterial transformation of ECFP_mVenus with Rifmo in E.coli in LB agar with kanamycin (50 µL/mL).


Table 1. Restriction digest conditions
Reactive Quantity
Restriction Enzyme 10X Buffer 5 µL
DNA (1 µg/ µL) 1 µL
Ncol restriction enzyme 1 µL
Xhol restriction enzyme 1 µL
BSA (1 µg/ µL) 0.2 µL
Nuclease-free water To 20 µL
Total volume 20 µL